OmniAb (OABI) Receivables - Net (2021 - 2026)
OmniAb (OABI) reported Receivables - Net of $12.6 million for Q1 2026, up 95.11% year-over-year from $6.5 million in Q1 2025, and up 71.03% quarter-over-quarter from $7.4 million in Q4 2025.
OmniAb (OABI) Receivables - Net (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Receivables - Net data on file, last reported at $12.6 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $12.6 million, up 95.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.6 million (up 95.11% YoY), and the FY2025 annual result was $7.4 million, up 40.17% from the prior year.
- Receivables - Net improved to $12.6 million in Q1 2026 per OABI's latest filing, from $7.4 million in the prior quarter.
- Over five years, Receivables - Net peaked at $30.3 million in Q4 2022 and troughed at $1.8 million in Q1 2023.
- A 5-year average of $7.3 million and a median of $5.7 million in 2023 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2023 and 2024: Receivables - Net plunged 87.31% in 2023, then soared 122.37% in 2024.
- A 5-year view of Receivables - Net shows it stood at $30.3 million in 2022, then sank by 87.31% to $3.8 million in 2023, then soared by 37.15% to $5.3 million in 2024, then surged by 40.17% to $7.4 million in 2025, then jumped by 71.03% to $12.6 million in 2026.
- Business Quant data shows OABI's Receivables - Net at $12.6 million in Q1 2026, $7.4 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.64 Mn |
| Mar 31, 2026 | 12.64 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Sep 30, 2025 | 3.10 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Jun 30, 2025 | 2.71 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Mar 31, 2025 | 6.48 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 3.84 Mn |
| Dec 31, 2023 | 3.84 Mn |